On the interaction between neuroleptics and antiparkinson drugs.
D000661:Amphetamine / Q000037:antagonists & inhibitors; D000818:Animals; D000978:Antiparkinson Agents / Q000494:pharmacology* / Q000627:therapeutic use; D001058:Apomorphine / Q000037:antagonists & inhibitors; D001480:Basal Ganglia Diseases / Q000139:chemically induced / Q000188:drug therapy; D001522:Behavior, Animal / Q000187:drug effects; D002375:Catalepsy / Q000139:chemically induced; D004285:Dogs; D004347:Drug Interactions; D006801:Humans; D051381:Rats; D012110:Reserpine; D014149:Tranquilizing Agents / Q000494:pharmacology* / Q000627:therapeutic use
D000978:Antiparkinson Agents; D014149:Tranquilizing Agents; D012110:Reserpine; D000661:Amphetamine; D001058:Apomorphine